Clinical trial
Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)
NCT00044902 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00044902 |
|---|---|
| Title | Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | epratuzumab |
| First posted | Sep 9, 2002 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: